The Enterprise Value as of September 2024 (TTM) for Aptose Biosciences Inc. (APTO) is -647435.00

According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -647435.00. This represents a change of -107.37% compared to the average of 8.78M of the last 4 quarters.

Aptose Biosciences Inc. (APTO) Historical Enterprise Value (quarterly & annually)

How has APTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptose Biosciences Inc. over the last ten years is -24374847.07. The current -647435.00 Enterprise Value has changed 165.62% with respect to the historical average. Over the past ten years (40 quarters), APTO's Enterprise Value was at its highest in in the June 2023 quarter at 21.73M. The Enterprise Value was at its lowest in in the December 2020 quarter at -90358740.00.

Aptose Biosciences Inc. (APTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptose Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptose Biosciences Inc. (APTO) Average Enterprise Value

How has APTO Enterprise Value performed in the past?

The current Enterprise Value of Aptose Biosciences Inc. (APTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aptose Biosciences Inc. (APTO) Enterprise Value vs. Peers

How is APTO’s Enterprise Value compared to its peers?

Aptose Biosciences Inc.’s Enterprise Value is less than CytomX Therapeutics, Inc. (63.41M), less than Instil Bio, Inc. (507.18M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Spero Therapeutics, Inc. (14.38M), less than Assembly Biosciences, Inc. (95.68M), less than Fortress Biotech, Inc. (57.28M), less than Mustang Bio, Inc. (6.27M), greater than Achilles Therapeutics plc (-61656377.00), less than Fortress Biotech, Inc. (57.28M), less than Gain Therapeutics, Inc. (21.41M), less than TFF Pharmaceuticals, Inc. (3.55M), less than aTyr Pharma, Inc. (138.44M), less than IN8bio, Inc. (10.13M), less than Lantern Pharma Inc. (28.90M), less than Affimed N.V. (57.82M), less than Leap Therapeutics, Inc. (37.18M), less than Adaptimmune Therapeutics plc (115.35M), less than Corvus Pharmaceuticals, Inc. (362.42M), less than Longboard Pharmaceuticals, Inc. (1.19B), greater than TRACON Pharmaceuticals, Inc. (-6065546.00), greater than Oncternal Therapeutics, Inc. (-1973598.00), greater than Aeglea BioTherapeutics, Inc. (-41964351.00),

Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.